Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis

Clinical Science

Volumn 129, Issue 2, 2015, Pages 147-158

  Tzeng, Huey En ^a,b   Chen, Po Chun ^a,c   Lin, Kai Wei ^a   Lin, Chih Yang ^a   Tsai, Chun Hao ^a,d   Han, Shao Min ^b   Teng, Chieh Lin ^b   Hwang, Wen Li ^b   Wang, Shih Wei ^e   Tang, Chih Hsin ^a,f,g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e MACKAY MEDICAL COLLEGE   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Chondrosarcoma; Endothelial progenitor cells

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VASCULOTROPIN; FGFR1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CHONDROSARCOMA; CHORIOALLANTOIC MEMBRANE ASSAY; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE TUMOR; CELL MOTION; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PARACRINE SIGNALING; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME; UPREGULATION; VASCULARIZATION;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHICK EMBRYO; CHONDROSARCOMA; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL PROGENITOR CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MICE, NUDE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARACRINE COMMUNICATION; PROTEIN KINASE INHIBITORS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION; TUMOR BURDEN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84935434212     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20140390     Document Type: Article

References (42)

1. Terek, R.M., Schwartz, G.K., Devaney, K., Glantz, L., Mak, S., Healey, J.H. and Albino, A.P. (1998) Chemotherapy and P-glycoprotein expression in chondrosarcoma. J. Orthop. Res. 16, 585-590.
2. Yuan, J., Dutton, C.M. and Scully, S.P. (2005) RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J. Orthop. Res. 23, 1467-1474.
3. Baeriswyl, V. and Christofori, G. (2009) The angiogenic switch in carcinogenesis. Semin. Cancer Biol. 19, 329-337.
4. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J.M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
5. Zhao, Y.H., Yuan, B., Chen, J., Feng, D.H., Zhao, B., Qin, C. and Chen, Y.F. (2013) Endothelial progenitor cells: therapeutic perspective for ischemic stroke. CNS Neurosci. Ther. 19, 67-75.
6. Patenaude, A., Parker, J. and Karsan, A. (2010) Involvement of endothelial progenitor cells in tumor vascularization. Microvasc. Res. 79, 217-223.
7. Kirton, J.P. and Xu, Q. (2010) Endothelial precursors in vascular repair. Microvasc. Res. 79, 193-199.
8. Gao, D., Nolan, D., McDonnell, K., Vahdat, L., Benezra, R., Altorki, N. and Mittal, V. (2009) Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim. Biophys. Acta 1796, 33-40.
9. Hase, T., Kawashiri, S., Tanaka, A., Nozaki, S., Noguchi, N., Kato, K., Nakaya, H. and Nakagawa, K. (2006) Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma. J. Oral Pathol. Med. 35, 136-139.
10. Barclay, C., Li, A.W., Geldenhuys, L., Baguma-Nibasheka, M., Porter, G.A., Veugelers, P.J., Murphy, P.R. and Casson, A.G. (2005) Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin. Cancer Res. 11, 7683-7691.
11. Uria, J.A., Balbin, M., Lopez, J.M., Alvarez, J., Vizoso, F., Takigawa, M. and Lopez-Otin, C. (1998) Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am. J. Pathol. 153, 91-101.
12. Bergers, G. and Benjamin, L.E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401-410.
13. Sugimoto, H. and Nishino, H. (1996) [Effect of recombinant human basic fibroblast growth factor (bFGF) on the growth of human tumor cell lines]. Hum. Cell. 9, 129-140.
14. Coppola, G., Atlas-White, M., Katsahambas, S., Bertolini, J., Hearn, M.T. and Underwood, J.R. (1997) Effect of intraperitoneally, intravenously and intralesionally administered monoclonal anti-β-FGF antibodies on rat chondrosarcoma tumor vascularization and growth. Anticancer Res. 17, 2033-2039.
15. Wang, H.H., Lin, C.A., Lee, C.H., Lin, Y.C., Tseng, Y.M., Hsieh, C.L., Chen, C.H., Tsai, C.H., Hsieh, C.T., Shen, J.L. et al. (2011) Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells. ACS Nano 5, 4337-4344.
16. Wang, H.H., Su, C.H., Wu, Y.J., Li, J.Y., Tseng, Y.M., Lin, Y.C., Hsieh, C.L., Tsai, C.H. and Yeh, H.I. (2013) Reduction of connexin43 in human endothelial progenitor cells impairs the angiogenic potential. Angiogenesis 16, 553-560.
17. Chung, C.H., Chang, C.H., Chen, S.S., Wang, H.H., Yen, J.Y., Hsiao, C.J., Wu, N.L., Chen, Y.L., Huang, T.F., Wang, P.C. et al. (2013) Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway. Evid. Based Complement. Alternat. Med. 2013, 943187.
18. Lam, K., Rao, V.S. and Qasba, P.K. (1998) Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1. J. Biomol. Struct. Dyn. 15, 1009-1027.
19. Gu, Y., Xue, C., Zhu, J., Sun, H., Ding, F., Cao, Z. and Gu, X. (2014) Basic fibroblast growth factor (bFGF) facilitates differentiation of adult dorsal root ganglia-derived neural stem cells toward Schwann cells by binding to FGFR-1 through MAPK/ERK activation. J. Mol. Neurosci. 52, 538-551.
20. Zetser, A., Bashenko, Y., Edovitsky, E., Levy-Adam, F., Vlodavsky, I. and Ilan, N. (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 66, 1455-1463.
21. Ahluwalia, A. and Tarnawski, A.S. (2012) Critical role of hypoxia sensor HIF-1α in VEGF gene activation: implications for angiogenesis and tissue injury healing. Curr. Med. Chem. 19, 90-97.
22. Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A. and Seo, H. (2002) Inhibition of NF-κB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat. 73, 237-243.
23. Fong, Y.C., Yang, W.H., Hsu, S.F., Hsu, H.C., Tseng, K.F., Hsu, C.J., Lee, C.Y. and Scully, S.P. (2007) 2-Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J. Orthop. Res. 25, 1106-1114.
24. Welti, J., Loges, S., Dimmeler, S. and Carmeliet, P. (2013) Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J. Clin. Invest. 123, 3190-3200.
25. Kubo, T., Shimose, S., Fujimori, J., Arihiro, K. and Ochi, M. (2013) Diversity of angiogenesis among malignant bone tumors. Mol. Clin. Oncol. 1, 131-136.
26. Haley, E.M. and Kim, Y. (2014) The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture. Cancer Lett. 346, 1-5.
27. Ribatti, D., Vacca, A., Rusnati, M. and Presta, M. (2007) The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev. 18, 327-334.
28. Korah, R.M., Sysounthone, V., Golowa, Y. and Wieder, R. (2000) Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res. 60, 733-740.
29. Maloof, P., Wang, Q., Wang, H., Stein, D., Denny, T.N., Yahalom, J., Fenig, E. and Wieder, R. (1999) Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 56, 153-167.
30. Li, Q., Gao, S., Yu, Y., Wang, W., Chen, X., Wang, R., Li, T., Wang, C., Li, X. and Wu, X. (2012) A novel bFGF antagonist peptide inhibits breast cancer cell growth. Mol. Med. Rep. 6, 210-214.
31. -: promoting the G0/G1→G2/S transition. J. Breast Cancer 15, 388-392.
32. Hillen, F. and Griffioen, A.W. (2007) Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 26, 489-502.
33. Kopp, H.G., Avecilla, S.T., Hooper, A.T. and Rafii, S. (2005) The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology 20, 349-356.
34. Bremnes, R.M., Camps, C. and Sirera, R. (2006) Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51, 143-158.
35. Mohammadi, M., Honegger, A.M., Rotin, D., Fischer, R., Bellot, F., Li, W., Dionne, C.A., Jaye, M., Rubinstein, M. and Schlessinger, J. (1991) A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-γ 1. Mol. Cell. Biol. 11, 5068-5078.
36. Chen, Y., Li, X., Eswarakumar, V.P., Seger, R. and Lonai, P. (2000) Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene 19, 3750-3756.
37. Weinstein, D.C., Marden, J., Carnevali, F. and Hemmati-Brivanlou, A. (1998) FGF-mediated mesoderm induction involves the Src-family kinase Laloo. Nature 394, 904-908.
38. O'Neill, E. and Kolch, W. (2004) Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br. J. Cancer 90, 283-288.
39. Lu, Q., Wang, C., Pan, R., Gao, X., Wei, Z., Xia, Y. and Dai, Y. (2013) Histamine synergistically promotes bFGF-induced angiogenesis by enhancing VEGF production via H1 receptor. J. Cell. Biochem. 114, 1009-1019.
40. Belsches, A.P., Haskell, M.D. and Parsons, S.J. (1997) Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front. Biosci. 2, d501-d518.
41. Schrage, Y.M., Briaire-de Bruijn, I.H., de Miranda, N.F., van Oosterwijk, J., Taminiau, A.H., van Wezel, T., Hogendoorn, P.C. and Bovee, J.V. (2009) Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment. Cancer Res. 69, 6216-6222.
42. van Oosterwijk, J.G., van Ruler, M.A., Briaire-de Bruijn, I.H., Herpers, B., Gelderblom, H., van de Water, B. and Bovee, J.V. (2013) Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells. Br. J. Cancer 109, 1214-1222.